These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo. Kuroda H; Mabuchi S; Kozasa K; Yokoi E; Matsumoto Y; Komura N; Kawano M; Hashimoto K; Sawada K; Kimura T Immunotherapy; 2017 Sep; 9(10):805-817. PubMed ID: 28877631 [TBL] [Abstract][Full Text] [Related]
4. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862 [TBL] [Abstract][Full Text] [Related]
5. The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations. Sasano T; Mabuchi S; Kozasa K; Kuroda H; Kawano M; Takahashi R; Komura N; Yokoi E; Matsumoto Y; Hashimoto K; Sawada K; Morii E; Kimura T Clin Cancer Res; 2018 Aug; 24(16):4018-4029. PubMed ID: 29752277 [No Abstract] [Full Text] [Related]
6. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs. Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209 [TBL] [Abstract][Full Text] [Related]
7. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review. Husseinzadeh N; Husseinzadeh HD Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063 [TBL] [Abstract][Full Text] [Related]
8. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. De Cicco P; Ercolano G; Ianaro A Front Immunol; 2020; 11():1680. PubMed ID: 32849585 [TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells in obstetrical and gynecological diseases. Zheng ZM; Yang HL; Lai ZZ; Wang CJ; Yang SL; Li MQ; Shao J Am J Reprod Immunol; 2020 Aug; 84(2):e13266. PubMed ID: 32418253 [TBL] [Abstract][Full Text] [Related]
10. Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy. Li X; Zhong J; Deng X; Guo X; Lu Y; Lin J; Huang X; Wang C Front Immunol; 2021; 12():754196. PubMed ID: 35003065 [TBL] [Abstract][Full Text] [Related]
11. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade. Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349 [TBL] [Abstract][Full Text] [Related]
12. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies. Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274 [TBL] [Abstract][Full Text] [Related]
13. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
14. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170 [TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives. Safari E; Ghorghanlu S; Ahmadi-Khiavi H; Mehranfar S; Rezaei R; Motallebnezhad M J Cell Physiol; 2019 Jul; 234(7):9966-9981. PubMed ID: 30537008 [TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors]. He Y; Wang Y; Ji C; Liu Y; Wu YM Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326 [No Abstract] [Full Text] [Related]